This post was co-authored by Martha Sweezy, Dilara Ally, Laure Tobiasz Veltz, Alexandra Comeau, Clare Bumpus, Tori Blot, Fiona Kate Rice, Brian Orr, Hanna Soumerai Rea, and Zev Schuman-Olivier.
A new study published last week suggests the psychedelic drug MDMA, also known as Ecstasy or Molly, can reduce symptoms of post-traumatic stress disorder, and some expect the treatment to be approved ...
Morning Overview on MSN
Psychedelics reshape myelin and may rewrite PTSD in the brain
A preclinical study published in Biological Psychiatry has found that repeated low doses of psilocybin and MDMA reshape ...
The U.S. Department of Veterans Affairs advocates standard treatments for PTSD, including "exposure-based" treatments, which involve having sufferers repeatedly re-experience the traumatic event. The ...
A randomized controlled trial in 234 military personnel and veterans from four Texas locations found clinically significant reductions in PTSD symptoms in more than 60 percent of patients and ...
NEW YORK, Jan. 19, 2022 /PRNewswire/ -- Neurovation Labs, Inc., a biotech company targeting physical biomarkers of PTSD for comprehensive diagnosis and treatment, today announced that the U.S. Patent ...
I work with adults on grief/loss, depression, anxiety, stress management, life transitions, relationship challenges, couples facing difficulty at any stage of their relationship, as well as with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results